Stem Cells: A Promising Therapeutic Target for COVID-19
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Stem Cell Discovery
- Vol. 12 (01), 1-27
- https://doi.org/10.4236/scd.2022.121001
Abstract
A large variety of therapeutic products have been developed as vaccines or treatments of COVID-19 infection. Meanwhile SARS-CoV-2 continues to mutate and spread. The severe COVID-19 patients have limited treatment options. Therefore, mesenchymal stem cells (MSCs) are proposed as another therapeutic target. They are known for their regenerative and immunomodulatory properties. They showed potent efficacy and safety abilities for the treatment of critical COVID-19 patients and intriguing benefits in reducing lungs damage, mortality, and cytokine storm in several clinical studies. Another promising treatment option is the use of dental pulp stem cells (DPSCs) to combat SARS-CoV-2, despite the fact that detailed therapeutic strategies and mechanisms are still lacking. In this review we shed light on the immune response against COVID-19 infection and the relevant knowledge considering the role of MSCs in innate and adaptive immune responses to better understand the immune-physiological mechanisms of MSCs treatment. Lastly, we summarize the latest progress in clinical and research studies suggesting potential MSCs/DPSCs as therapeutic targets in battling COVID-19.Keywords
This publication has 96 references indexed in Scilit:
- MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune ModulationStem Cells International, 2013
- Mesenchymal stem cells: a new trend for cell therapyActa Pharmacologica Sinica, 2013
- Directed Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell ProgrammingStem Cells International, 2012
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cellsBlood, 2005
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Establishment in culture of pluripotential cells from mouse embryosNature, 1981